Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 99% | 534.44 | 575 / 578 | 96% | 21.01 | 1104 / 1155 |
esophagus | 96% | 250.81 | 1383 / 1445 | 98% | 30.58 | 180 / 183 |
thymus | 96% | 247.68 | 630 / 653 | 96% | 25.75 | 580 / 605 |
stomach | 99% | 324.60 | 355 / 359 | 91% | 22.58 | 261 / 286 |
ovary | 93% | 473.33 | 167 / 180 | 96% | 18.67 | 412 / 430 |
uterus | 88% | 299.41 | 149 / 170 | 95% | 20.82 | 436 / 459 |
intestine | 89% | 288.19 | 855 / 966 | 87% | 16.32 | 460 / 527 |
kidney | 100% | 734.16 | 89 / 89 | 72% | 11.65 | 648 / 901 |
bladder | 95% | 375.14 | 20 / 21 | 74% | 13.19 | 374 / 504 |
breast | 97% | 362.95 | 446 / 459 | 58% | 6.25 | 647 / 1118 |
prostate | 96% | 338.89 | 236 / 245 | 53% | 4.22 | 264 / 502 |
skin | 85% | 252.57 | 1534 / 1809 | 58% | 7.29 | 274 / 472 |
pancreas | 49% | 75.80 | 161 / 328 | 91% | 12.10 | 162 / 178 |
adrenal gland | 88% | 189.74 | 228 / 258 | 47% | 9.85 | 108 / 230 |
liver | 75% | 745.36 | 170 / 226 | 57% | 7.27 | 231 / 406 |
lymph node | 0% | 0 | 0 / 0 | 100% | 92.16 | 29 / 29 |
spleen | 100% | 955.84 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 39.24 | 44 / 45 |
adipose | 98% | 474.48 | 1177 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 96% | 637.96 | 894 / 929 | 0% | 0 | 0 / 0 |
heart | 69% | 120.34 | 596 / 861 | 0% | 0 | 0 / 0 |
brain | 32% | 68.99 | 835 / 2642 | 30% | 3.32 | 208 / 705 |
blood vessel | 60% | 108.65 | 803 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 39% | 2.39 | 31 / 80 |
muscle | 35% | 46.23 | 282 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0019221 | Biological process | cytokine-mediated signaling pathway |
GO_0016567 | Biological process | protein ubiquitination |
GO_0046426 | Biological process | negative regulation of receptor signaling pathway via JAK-STAT |
GO_0030225 | Biological process | macrophage differentiation |
GO_0046854 | Biological process | phosphatidylinositol phosphate biosynthetic process |
GO_0001932 | Biological process | regulation of protein phosphorylation |
GO_0046627 | Biological process | negative regulation of insulin receptor signaling pathway |
GO_0043377 | Biological process | negative regulation of CD8-positive, alpha-beta T cell differentiation |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0001817 | Biological process | regulation of cytokine production |
GO_0071230 | Biological process | cellular response to amino acid stimulus |
GO_0043372 | Biological process | positive regulation of CD4-positive, alpha-beta T cell differentiation |
GO_0045591 | Biological process | positive regulation of regulatory T cell differentiation |
GO_0007259 | Biological process | cell surface receptor signaling pathway via JAK-STAT |
GO_0042532 | Biological process | negative regulation of tyrosine phosphorylation of STAT protein |
GO_0045444 | Biological process | fat cell differentiation |
GO_0005942 | Cellular component | phosphatidylinositol 3-kinase complex |
GO_0031410 | Cellular component | cytoplasmic vesicle |
GO_0036464 | Cellular component | cytoplasmic ribonucleoprotein granule |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0004860 | Molecular function | protein kinase inhibitor activity |
GO_0005159 | Molecular function | insulin-like growth factor receptor binding |
GO_0019901 | Molecular function | protein kinase binding |
GO_0019210 | Molecular function | kinase inhibitor activity |
GO_0046935 | Molecular function | 1-phosphatidylinositol-3-kinase regulator activity |
GO_0005515 | Molecular function | protein binding |
Gene name | SOCS1 |
Protein name | Suppressor of cytokine signaling 1 Suppressor of cytokine signaling 1 (SOCS-1) (JAK-binding protein) (JAB) (STAT-induced STAT inhibitor 1) (SSI-1) (Tec-interacting protein 3) (TIP-3) |
Synonyms | TIP3 SSI1 hCG_14617 |
Description | FUNCTION: Essential negative regulator of type I and type II interferon (IFN) signaling, as well as that of other cytokines, including IL2, IL4, IL6 and leukemia inhibitory factor (LIF) . Downregulates cytokine signaling by inhibiting the JAK/STAT signaling pathway. Acts by binding to JAK proteins and to IFNGR1 and inhibiting their kinase activity. In vitro, suppresses Tec protein-tyrosine activity . Regulates IFN-gamma (IFNG)-mediated sensory neuron survival (By similarity). Probable substrate recognition component of an ECS (Elongin BC-CUL2/5-SOCS-box protein) E3 ubiquitin ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins . . |
Accessions | Q4JHT5 ENST00000332029.4 O15524 ENST00000644787.1 |